Relay Therapeutics, Inc.
SHP2 PHOSPHATASE INHIBITORS AND METHODS OF MAKING AND USING THE SAME

Abstract:

The disclosure is in part directed to crystalline forms of (R)-1'-(3-(3,4-dihydro-1,5-naphthyridin-1(2H)-yl)-1H-pyrazolo[3,4-b]pyraz- in-6-yl)-3H-spiro[benzofuran-2,4'-piperidin]-3-amine, its salt, and variants thereof.